arrow
A

Anna Parfieniuk-Kowerda

Medical University of Bialystok
H指数:14
被引数:762

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Does rheumatoid arthritis affect the course of chronic hepatitis C and outcomes of antiviral treatment?

类风湿关节炎是否影响慢性丙型肝炎的病程及抗病毒治疗效果?

2026-05-281
PRE
Increased frequencies of human Th-17 CD4+ T-cells and decreased T-regulatory cells in patients with early and advanced metabolic dysfunction-associated steatotic liver disease

早期和晚期代谢功能障碍相关脂肪性肝病患者中,人Th-17 CD4+ T细胞频率增加,调节性T细胞频率减少。

2025-08-220
OA
The Role of Chemotactic Cytokines in Tick-Borne Encephalitis

趋化性细胞因子在蜱传脑炎中的作用

CELLS
IF5.2
2025-03-250
OA
Treatment of Hepatitis C Virus Infections Among Patients of Ukrainian Origin During the Influx of War Refugees to Poland

在战争难民涌入波兰期间,乌克兰裔患者中丙型肝炎病毒感染的治疗

2024-12-150
OAAI
Loss to follow-up of patients after antiviral treatment as an additional barrier to HCV elimination(vol 22, 486, 2024)

抗病毒治疗后患者的随访损失作为HCV消除的额外障碍 (第22卷,486,2024)

2024-11-080
OAAI
Real-world experience with direct-acting antiviral therapy in HCV-infected patients with cirrhosis and esophageal varices

HCV感染的肝硬化和食管静脉曲张患者直接抗病毒治疗的真实世界经验

2024-08-201
OAAI
Real-world effectiveness and safety of direct-acting antivirals in hepatitis C virus patients with mental disorders

在丙型肝炎病毒精神障碍患者中直接抗病毒药物的真实世界有效性和安全性

2023-07-076
OAAI
Changes in characteristics of patients with hepatitis C virus-related cirrhosis from the beginning of the interferon-free era
2023-04-0711
OAAI
Implementation of the web-based calculator estimating odds ratio of severe COVID-19 for unvaccinated individuals in a country with high coronavirus-related death toll
2022-09-291
OAAI
Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection
2022-01-135
OAAI
Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics
2021-07-2517
OAAI